ARCHIVES

Turmoil in Texas: DePinho Recommended AVEO Stock on CNBC Six Days After FDA Said New Trial Was Needed

This article is from The Cancer Letter archive.

Vol. 39 No. 19 | May 10, 2013

Download PDF Visit The Full Archive

Related Articles

UNC Lineberger Appoints Two, Zaret Wins Chair At Fox Chase.

February 25, 2000

FDA Purges Quality of Life Claims from Oncology Label for ESAs.

March 16, 2007

Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent

January 27, 2012

Study: Oncotype DX Score Can Predict Local Recurrence

March 29, 2013

Penn Begins Clinical Trial Of A Vaccine For Breast Cancer Based On Telomerase

February 27, 2004

NIAID Advisors Ok Recompetition of Pediatric ACTGs

February 14, 1992